Innovations in isolating, sequencing, and analyzing cell-free DNA (cfDNA) — short fragments of DNA released from tissues into the blood — are accelerating diagnostics, from infectious disease identification to prenatal genetic screening.

Free Download: State of healthcare

Despite the impact of the Covid-19 pandemic, funding trended up each quarter since Q1’20. Find out more in our full report.

Detecting disease earlier can improve patient outcomes and lower disease management costs. For example, Covid-19 cfDNA could help physicians monitor the severity of the infection for hospitalized patients.

Want the full post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post This DNA-Based Tech Could Transform How We Diagnose And Treat Disease appeared first on CB Insights Research.

By admin